Large-scale testing (Phase 3)Ended earlyNCT03008616
What this trial is testing
Study of the Efficacy and Safety of AMAG-423 (Digoxin Immune Fab) in Antepartum Subjects With Severe Preeclampsia
Who this might be right for
Severe Preeclampsia
AMAG Pharmaceuticals, Inc. 59